Cargando…

Current Status of PRP Manufacturing Requirements & European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine

Providing accurate and up-to-date practical tools enabling oversight of platelet-rich plasma (PRP) legislation and of the appropriate standards to be implemented for its manufacture and use in Europe is a demanding task. This is due to rapid medico-technological advancements, slowness and disparity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sebbagh, Patrick, Cannone, Alessandro, Gremion, Gerald, Gremeaux, Vincent, Raffoul, Wassim, Hirt-Burri, Nathalie, Michetti, Murielle, Abdel-Sayed, Philippe, Laurent, Alexis, Wardé, Nathalie, Applegate, Lee Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044789/ https://www.ncbi.nlm.nih.gov/pubmed/36978683 http://dx.doi.org/10.3390/bioengineering10030292

Ejemplares similares

Process Optimization and Efficacy Assessment of Standardized PRP for Tendinopathies in Sports Medicine: Retrospective Study of Clinical Files and GMP Manufacturing Records in a Swiss University Hospital
por: Sebbagh, Patrick, et al.
Publicado: (2023)

Optimized Manufacture of Lyophilized Dermal Fibroblasts for Next-Generation Off-the-Shelf Progenitor Biological Bandages in Topical Post-Burn Regenerative Medicine
por: Laurent, Alexis, et al.
Publicado: (2021)

Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine
por: Laurent, Alexis, et al.
Publicado: (2021)

Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology
por: Laurent, Alexis, et al.
Publicado: (2020)

Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland
por: Laurent, Alexis, et al.
Publicado: (2021)

Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation
por: Laurent, Alexis, et al.
Publicado: (2021)

Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care
por: Laurent, Alexis, et al.
Publicado: (2023)

Evolution of Biological Bandages as First Cover for Burn Patients
por: Abdel-Sayed, Philippe, et al.
Publicado: (2019)

Industrial Biotechnology Conservation Processes: Similarities with Natural Long-Term Preservation of Biological Organisms
por: Laurent, Alexis, et al.
Publicado: (2023)

Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine
por: Jeannerat, Annick, et al.
Publicado: (2021)

Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care
por: Chen, Xi, et al.
Publicado: (2023)

Bringing Safe and Standardized Cell Therapies to Industrialized Processing for Burns and Wounds
por: Laurent, Alexis, et al.
Publicado: (2020)

Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification
por: Philippe, Virginie, et al.
Publicado: (2023)

Retrospective Analysis of Autologous Chondrocyte-Based Cytotherapy Production for Clinical Use: GMP Process-Based Manufacturing Optimization in a Swiss University Hospital
por: Philippe, Virginie, et al.
Publicado: (2022)

Surgical Management Evolution Between 2 Massive Burn Cases at 17-Year Interval: Contribution of Cell Therapies in Improving the Surgical Care
por: Monnier, Sandra, et al.
Publicado: (2020)

Bio-Enhanced Neoligaments Graft Bearing FE002 Primary Progenitor Tenocytes: Allogeneic Tissue Engineering & Surgical Proofs-of-Concept for Hand Ligament Regenerative Medicine
por: Jeannerat, Annick, et al.
Publicado: (2023)

Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation
por: Laurent, Alexis, et al.
Publicado: (2021)

Corrigendum to: Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs
por: Chemali, Michèle, et al.
Publicado: (2021)

Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs
por: Chemali, Michèle, et al.
Publicado: (2021)

Lyophilized Progenitor Tenocyte Extracts: Sterilizable Cytotherapeutic Derivatives with Antioxidant Properties and Hyaluronan Hydrogel Functionalization Effects
por: Laurent, Alexis, et al.
Publicado: (2023)

PRP and BMAC for Musculoskeletal Conditions via Biomaterial Carriers
por: Yamaguchi, Fabio S. M., et al.
Publicado: (2019)

Combination of Hyaluronan and Lyophilized Progenitor Cell Derivatives: Stabilization of Functional Hydrogel Products for Therapeutic Management of Tendinous Tissue Disorders
por: Laurent, Alexis, et al.
Publicado: (2021)

Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care
por: Al-Dourobi, Karim, et al.
Publicado: (2021)

The PRP Question
por: Wojtys, Edward M.
Publicado: (2012)

Umbilical Cord PRP vs. Autologous PRP for the Treatment of Hip Osteoarthritis
por: Mazzotta, Alessandro, et al.
Publicado: (2022)

Biologicals and Fetal Cell Therapy for Wound and Scar Management
por: Hirt-Burri, Nathalie, et al.
Publicado: (2011)

Performance of PRP Associated with Porous Chitosan as a Composite Scaffold for Regenerative Medicine
por: Shimojo, Andréa Arruda Martins, et al.
Publicado: (2015)

PRP therapy classification
por: Yamato, Masayuki, et al.
Publicado: (2015)

PRP Enriched with Hyaluronic Acid -PRP from Rat Protocol and Method of Preparation-
por: MARINESCU, ELENA-ALEXANDRA, et al.
Publicado: (2021)

Comparison of Efficacy of Platelet-Rich Plasma (PRP) With PRP Microneedling in Androgenetic Alopecia
por: Muhammad, Anjum, et al.
Publicado: (2022)

Quaternary Structure Changes for PrP(Sc) Predate PrP(C) Downregulation and Neuronal Death During Progression of Experimental Scrapie Disease
por: Eskandari-Sedighi, Ghazaleh, et al.
Publicado: (2020)

Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies
por: Everts, Peter A., et al.
Publicado: (2022)

Thermo-Responsive Hyaluronan-Based Hydrogels Combined with Allogeneic Cytotherapeutics for the Treatment of Osteoarthritis
por: Porcello, Alexandre, et al.
Publicado: (2023)

Ex Vivo Functional Benchmarking of Hyaluronan-Based Osteoarthritis Viscosupplement Products: Comprehensive Assessment of Rheological, Lubricative, Adhesive, and Stability Attributes
por: Porcello, Alexandre, et al.
Publicado: (2023)

Hyperuricemic PRP in Tendon Cells
por: Andia, I., et al.
Publicado: (2014)

PRP For the Treatment of Cartilage Pathology
por: Kon, Elizaveta, et al.
Publicado: (2013)

PRP Augmentation for ACL Reconstruction
por: Andriolo, Luca, et al.
Publicado: (2015)

Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP
por: Sakudo, Akikazu, et al.
Publicado: (2015)

Abstract: Nanofat+Prp Vs Prp in Androgenic Alopecia. An Intra-Patient Case-Control Study
por: Vestita, Michelangelo, et al.
Publicado: (2018)

Efficient decellularization of equine tendon with preserved biomechanical properties and cytocompatibility for human tendon surgery indications
por: Aeberhard, Pierre‐Arnaud, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_55umiis764sancftjasvrcfhqo